162 Addendum RESEARCH DATAMANAGEMENT The data described in this thesis were obtained during my PhD period at the departments of Medical Oncology and Medical Imaging (Nuclear Medicine) of the Radboud University Medical Centre (Radboudumc) in Nijmegen, the Netherlands. All prospective clinical studies (chapter 2,3,5,6) were conducted in accordance with the principles of the Declaration of Helsinki. The medical and ethical review board Committee on Research Involving Human Subjects Region Arnhem Nijmegen, Nijmegen, the Netherlands has given approval to conduct these studies. All three clinical trials were registered on ClinicalTrials.gov, a database of privately and publicly funded clinical studies conducted around the world. All data is archived according to the findable, Accessible, Interoperable and Reusable (FAIR) principles1. Findable The primary and secondary data were stored at the Radboudumc department servers as well as CASTOR, a cloud-based clinical data management platform. Raw and processed imaging data (e.g., CT and PET/CT) are backed-up on university servers belonging to the department of Medical Imaging. For the IMPACT-RCC study (chapter 2,3), the anonymized imaging data was stored at BMIA-XNAT (htps://xnat.bmia.nl/). Accessible Data is accessible by senior staff members who are involved in the research. The data presented in chapter 2,3,5 and 6 have been published in scientific articles. Additional data associated with the chapters in this thesis are available via the corresponding authors upon request. Interoperable All protocols and data are documented in English Reusable The data will be saved for 15 years after termination of the study. Using these patient data in future research is only possible after a renewed permission by the patient as recorded in the informed consent. REFERENCES 1. Wilkinson MD, Dumontier M, Aalbersberg IJ, et al. The FAIR Guiding Principles for scientific data management and stewardship. Scientific Data. 2016;3(1):160018.
RkJQdWJsaXNoZXIy MTk4NDMw